文献速递心肺康复

扩展版康复复杂性量表在院内肺康复中的应用价值

Is the Rehabilitation Complexity Scale Useful in Individuals Undergoing In-Hospital Pulmonary Rehabilitation?
PubMed 文献 · Arch Phys Med Rehabil · 2024-07-22

结果显示RCS-E v13在不同疾病组间存在差异,与BI、6MWT、SPPB等结局指标相关,且对肺康复干预具有反应性,可用于反映患者的照护负担。

要点

  • RCS-E v13在气管造口通气组入院分值最高(17[15-18]),显著高于其他组(P<.001)。
  • RCS-E v13与BI、6MWT、SPPB强相关,与MRC和BiD中度相关(r=.43-.60)。
  • 肺康复后RCS-E v13及所有结局指标均显著改善(P<.001),RCS-E v13效应量大(Cohen's d=-2.0984)。

核心结论

  • RCS-E v13在不同慢性呼吸系统疾病患者中分值不同,对肺康复具有反应性,构念效度和并发效度良好,且与多数公认的肺康复结局指标相关,其评分可提供患者照护负担的有用信息。

主要发现

  • 入院时RCS-E v13中位数(四分位距)在气管造口通气组为17(15-18),COPD组为8(7-10),慢性呼吸衰竭组为10(9-12),其他疾病组为8(8-10),组间比较P<.001。
  • 入院和出院时RCS-E v13与BI、6MWT、SPPB强相关,与MRC和BiD中度相关(r=.43-.60)。
  • 肺康复后所有组RCS-E v13及所有结局指标均显著改善(P<.001),改善幅度因变量不同而异。
  • 总体组中RCS-E v13变化效应量高(Cohen's d=-2.0984),CAT(d=-1.1937)、MRC(d=-1.0505)、BiD(d=-.9364)、SPPB(d=.9231)效应量高,6MWT(d=.7670)和BI(d=.6574)效应量中等。

关键数值与推荐

  • RCS-E v13入院分值:气管造口通气组17(15-18),慢性呼吸衰竭组10(9-12),COPD组8(7-10),其他疾病组8(8-10),组间P<.001。
  • RCS-E v13与BI、6MWT、SPPB强相关,与MRC、BiD中度相关(r=.43-.60)。
  • 肺康复后RCS-E v13及所有结局指标均显著改善(P<.001)。
  • RCS-E v13变化的效应量Cohen's d=-2.0984,CAT为-1.1937,MRC为-1.0505,BiD为-.9364,SPPB为.9231,6MWT为.7670,BI为.6574。

临床怎么用

  • RCS-E v13可用于评估院内肺康复患者的康复复杂性及照护负担,辅助临床决策。
  • RCS-E v13评分随疾病类型不同而变化,解读时应结合患者具体疾病组别。
  • RCS-E v13对肺康复干预反应敏感,可作为监测康复效果的工具之一。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess validity and responsiveness of the Extended Rehabilitation Complexity Scale (RCS-E v13) to in-hospital pulmonary rehabilitation (PR) in individuals with chronic respiratory diseases (CRD). DESIGN: Cross-sectional, multicentric study. Assessments in individuals attending units on 2 nonconsecutive days. SETTING: Fourteen in-hospital PR units. PARTICIPANTS: Five hundred forty-seven individuals (59.2% male, age 72y [range, 65-78y]): 317 with chronic respiratory failure because of various causes (CRF); 96 with chronic obstructive pulmonary disease without CRF (COPD), 39 tracheostomized and ventilated (TX/V), and 95 with other diseases (Miscellaneous). INTERVENTION: Assessment of RCS-E v13 before and after the PR program. MAIN OUTCOME MEASURES: RCS-E v13 and outcome measures: Barthel Index (BI), Barthel Index Dyspnea (BiD), Medical Research Council scale for dyspnea (MRC), COPD Assessment Test (CAT), Short Physical Performance Battery (SPPB), and 6-minute walk test (6MWT). RESULTS: The highest RCS-E v13 admission values (median [interquartile range]) were found in TX/V (17 [15-18]) as compared with other groups (8 [7-10], 10 [9-12], and 8 [8-10] in COPD, CRF, and Miscellaneous, respectively, P<.001). At admission and discharge, RCS-E v13 correlated strongly with BI, 6MWT, and SPPB and moderately with MRC and BiD (r=.43-.60). After the program, RCS-E v13 as well as all outcome measures improved significantly in all groups (P<.001 for all). The size of improvement was different among groups according to the different variables. In the overall group, the effect size was high for changes in RCS-E v13 (Cohen's d=-2.0984), CAT (d=-1.1937), MRC (d=-1.0505), BiD (d=-.9364), and SPPB (d=.9231) whereas it was moderate for 6MWT (d=.7670) and BI (d=.6574). CONCLUSIONS: RCS-E v13 varies according to different CRD, is responsive to PR, has good construct and concurrent validity, and correlates with most of the accepted outcome measures of PR. Its scoring may provide useful information on the care burden of individuals undergoing PR.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Is the Rehabilitation Complexity Scale Useful in Individuals Undergoing In-Hospital Pulmonary Rehabilitation? Arch Phys Med Rehabil. 2024. PMID: 39047855. doi:10.1016/j.apmr.2024.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。